- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,519GBP
- Report
- June 2026
- 179 Pages
Global
From €5317EUR$5,850USD£4,586GBP
- Report
- June 2026
- 340 Pages
Global
From €5317EUR$5,850USD£4,586GBP
- Report
- June 2026
- 287 Pages
Global
From €5317EUR$5,850USD£4,586GBP
- Report
- June 2026
- 451 Pages
Global
From €5317EUR$5,850USD£4,586GBP
- Report
- June 2026
- 192 Pages
Global
From €5317EUR$5,850USD£4,586GBP
- Report
- June 2026
- 478 Pages
Global
From €5317EUR$5,850USD£4,586GBP
- Report
- June 2026
- 286 Pages
Global
From €5317EUR$5,850USD£4,586GBP
- Report
- June 2026
- 187 Pages
Global
From €3222EUR$3,545USD£2,779GBP
€3580EUR$3,939USD£3,088GBP
- Report
- June 2026
- 192 Pages
Global
From €3222EUR$3,545USD£2,779GBP
€3580EUR$3,939USD£3,088GBP
- Report
- January 2026
- 180 Pages
Global
From €4090EUR$4,500USD£3,527GBP
- Report
- January 2026
- 180 Pages
Global
From €4090EUR$4,500USD£3,527GBP
- Report
- June 2026
- 193 Pages
Global
From €5317EUR$5,850USD£4,586GBP
- Report
- March 2026
- 400 Pages
Global
From €4498EUR$4,949USD£3,879GBP
- Report
- April 2026
- 148 Pages
Global
From €3635EUR$3,999USD£3,135GBP
- Report
- March 2026
- 149 Pages
Global
From €3635EUR$3,999USD£3,135GBP
- Report
- January 2026
- 130 Pages
Global
From €4317EUR$4,750USD£3,723GBP
- Report
- January 2026
- 286 Pages
Global
From €2272EUR$2,500USD£1,960GBP
- Report
- January 2026
- 281 Pages
Global
From €2272EUR$2,500USD£1,960GBP
- Report
- October 2025
- 150 Pages
Global
From €4408EUR$4,850USD£3,802GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more